ZD 0870

Drug Profile

ZD 0870

Alternative Names: D 0870; ICI D 0870; M 16354

Latest Information Update: 21 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AstraZeneca
  • Developer AstraZeneca; Mochida Pharmaceutical
  • Class Antifungals; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Chagas disease; Mycoses

Most Recent Events

  • 05 Oct 2000 A preclinical study has been added to the Parasitic Infections pharmacodynamics section
  • 03 Aug 1999 A study has been added to the drug interactions section
  • 16 Nov 1998 Discontinued-Preclinical for Chagas' disease in Venezuela (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top